Article ID Journal Published Year Pages File Type
2724604 The American Journal of Medicine 2009 10 Pages PDF
Abstract
In patients with coronary artery disease, long-acting CCBs (either dihydropyridines or nondihydropyridines), were associated with a reduction in the risk of stroke, angina pectoris, and heart failure, with similar outcomes for other cardiovascular events as the comparison group.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Medicine and Dentistry (General)
Preview
Long-Acting Calcium Antagonists in Patients with Coronary Artery Disease: A Meta-Analysis
Authors
, , , , ,